Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

YuFeng He

Showing results (151-160 of 155) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 155 results.
Cell Death Discovery|June 15, 2026
Sympathetic signaling activation alleviated acute respiratory distress syndrome via the HDC/SLC7A11 axis in lipopolysaccharide-induced macrophagesXing Lv, Chenhao Jiang, Xu Zhang, et al.
Frontiers in Immunology|October 30, 2023
Machine learning-based identification of CYBB and FCAR as potential neutrophil extracellular trap-related treatment targets in sepsisGuoHua You, XueGang Zhao, JianRong Liu, et al.
Nature Communications|October 17, 2025
Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumorsPengfei Ren, Rui Zhang, Yunfeng Wang, et al.
Immunity|March 1, 2025
Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cellsCe Luo, Rui Zhang, Rui Guo, et al.
Future Oncology (London, England)|July 30, 2025
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCCGuangmin Mao, Zhuocheng Xin, Qingsong Fan, et al.
Pageof 16

Showing results (151-160 of 155) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 155 results.
Cell Death Discovery|June 15, 2026
Sympathetic signaling activation alleviated acute respiratory distress syndrome via the HDC/SLC7A11 axis in lipopolysaccharide-induced macrophagesXing Lv, Chenhao Jiang, Xu Zhang, et al.
Frontiers in Immunology|October 30, 2023
Machine learning-based identification of CYBB and FCAR as potential neutrophil extracellular trap-related treatment targets in sepsisGuoHua You, XueGang Zhao, JianRong Liu, et al.
Nature Communications|October 17, 2025
Systematic benchmarking of high-throughput subcellular spatial transcriptomics platforms across human tumorsPengfei Ren, Rui Zhang, Yunfeng Wang, et al.
Immunity|March 1, 2025
Integrated computational analysis identifies therapeutic targets with dual action in cancer cells and T cellsCe Luo, Rui Zhang, Rui Guo, et al.
Future Oncology (London, England)|July 30, 2025
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCCGuangmin Mao, Zhuocheng Xin, Qingsong Fan, et al.
Pageof 16